Screening of the Dichloromethane: Methanolic Extract of Centella asiatica for Antibacterial Activities against Salmonella typhi, Escherichia coli, Shigella sonnei, Bacillus subtilis, and Staphylococcus aureus
Table 1
Zones of inhibition produced by the C. asiatica extract against bacteria strains in mm.
Group
Zones of inhibition (mm)
Treatment
Staphylococcus aureus
Escherichia coli
Salmonella typhi
Bacillus subtlis
Shigella sonnei
Negative control
DMSO
6.00 ± 0.00d
6.00 ± 0.00f
6.00 ± 0.00e
6.00 ± 0.00d
6.00 ± 0.00d
Positive control
Tetracycline
29.33 ± 0.67a
26.67 ± 0.33a
27.67 ± 0.33a
22.67 ± 0.33a
25.33 ± 0.33a
C. asiatica DCM: MeOH extract
15.625 mg/ml
6.00 ± 0.00d
6.00 ± 0.00f
6.00 ± 0.00e
6.00 ± 0.00d
6.00 ± 0.00d
31.25 mg/ml
6.00 ± 0.00d
6.00 ± 0.00f
6.00 ± 0.00e
6.00 ± 0.00d
6.00 ± 0.00d
62.5 mg/ml
6.00 ± 0.00d
7.33 ± 0.33e
6.00 ± 0.00e
6.00 ± 0.00d
6.00 ± 0.00d
125 mg/ml
6.00 ± 0.00d
8.67 ± 0.33d
8.00 ± 0.33d
6.00 ± 0.00d
7.33 ± 0.33d
250 mg/ml
9.67 ± 0.33c
13.67 ± 0.33c
10.67 ± 0.33c
7.67 ± 0.33c
9.00 ± 0.58c
500 mg/ml
12.00 ± 0.58b
16.33 ± 0.33b
13.00 ± 0.58b
9.67 ± 0.33b
15.67 ± 0.33b
Values are expressed as mean ± standard error of the mean (SEM) for triplicate reading. Values with the same superscript letter in the columns are not significantly different by one-way ANOVA followed by Tukey’s post-hoc test.